UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$388M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$359M |
| 3 |
ExxonMobil
XOM
|
+$284M |
| 4 |
TSMC
TSM
|
+$259M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$239M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$911M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$825M |
| 3 |
UBS Group
UBS
|
+$683M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$381M |
| 5 |
Willis Towers Watson
WTW
|
+$375M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.08% |
| 2 | Financials | 7.19% |
| 3 | Healthcare | 6.35% |
| 4 | Consumer Discretionary | 5.55% |
| 5 | Industrials | 4.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Sabra Healthcare REIT
SBRA
$5.37B
| $7.22M | ﹤0.01% |
485,081
-206,345
| -30% | -$2.82M |
|
2202
PUT
Western Digital
WDC
$150B
| $7.21M | ﹤0.01% |
192,100
-835,606
| -81% | -$34.3M |
|
2203
Intellia Therapeutics
NTLA
$1.67B
| $7.21M | ﹤0.01% |
99,179
-15,969
| -14% | -$1.35M |
|
2204
iShares MSCI Intl Value Factor ETF
IVLU
$4.56B
| $7.19M | ﹤0.01% |
282,612
+271,981
| +2,558% | +$7.04M |
|
|
AWP
2205
abrdn Global Premier Properties Fund
AWP
$367M
| $7.19M | ﹤0.01% |
371,991
+133,179
| +56% | +$2.5M |
|
2206
CALL
Yum! Brands
YUM
$41.1B
| $7.16M | ﹤0.01% |
60,400
-92,000
| -60% | -$11.3M |
|
2207
Lennox International
LII
$15.2B
| $7.15M | ﹤0.01% |
27,718
-6,858
| -20% | -$1.88M |
|
2208
First Trust Mid Cap Value AlphaDEX Fund
FNK
$231M
| $7.14M | ﹤0.01% |
153,124
+65,084
| +74% | +$3.02M |
|
2209
Westlake Chemical Partners
WLKP
$763M
| $7.12M | ﹤0.01% |
263,019
+773
| +0.3% | +$20.5K |
|
|
BLE
2210
DELISTED
BlackRock Municipal Income Trust II
BLE
| $7.12M | ﹤0.01% |
577,771
-53,015
| -8% | -$725K |
|
2211
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.94B
| $7.1M | ﹤0.01% |
95,690
+1,708
| +2% | +$126K |
|
|
Y
2212
DELISTED
Alleghany Corp
Y
| $7.1M | ﹤0.01% |
8,380
-8,141
| -49% | -$5.64M |
|
|
NEWR
2213
DELISTED
New Relic, Inc.
NEWR
| $7.1M | ﹤0.01% |
106,132
-36,741
| -26% | -$3.01M |
|
2214
Barclays
BCS
$94.1B
| $7.1M | ﹤0.01% |
898,378
+252,950
| +39% | +$2.58M |
|
2215
Sixth Street Specialty
TSLX
$1.81B
| $7.09M | ﹤0.01% |
304,552
+11,264
| +4% | +$264K |
|
2216
iShares Latin America 40 ETF
ILF
$3.83B
| $7.08M | ﹤0.01% |
233,043
-103,513
| -31% | -$2.73M |
|
|
PPL
2217
CALL
PPL Corp
PPL
$26.7B
| $7.08M | ﹤0.01% |
247,900
+60,900
| +33% | +$1.72M |
|
2218
CALL
Procter & Gamble
PG
$339B
| $7.07M | ﹤0.01% |
46,300
-25,700
| -36% | -$4.02M |
|
2219
PUT
NXP Semiconductors
NXPI
$60.4B
| $7.07M | ﹤0.01% |
38,200
+3,200
| +9% | +$631K |
|
2220
CALL
Live Nation Entertainment
LYV
$42.1B
| $7.06M | ﹤0.01% |
60,000
-49,200
| -45% | -$5.61M |
|
2221
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$1.39B
| $7.06M | ﹤0.01% |
160,959
-2,563
| -2% | -$109K |
|
2222
Schwab International Small-Cap Equity ETF
SCHC
$5.65B
| $7.05M | ﹤0.01% |
185,727
-14,892
| -7% | -$570K |
|
2223
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$794M
| $7.05M | ﹤0.01% |
190,981
-15,184
| -7% | -$509K |
|
|
SCHW
2224
CALL
Charles Schwab
SCHW
$187B
| $7.04M | ﹤0.01% |
83,500
-320,500
| -79% | -$28.2M |
|
2225
Ocugen
OCGN
$434M
| $7.03M | ﹤0.01% |
2,131,074
+1,305,248
| +158% | +$4.59M |
|
Similar funds
UBS Group's Q1 2022 Portfolio in Review
As of Q1 2022, UBS Group held 11,668 positions worth $300B, down 14% from $349B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group withdrew a net $29.5B in Q1 2022, closing 1,161 positions and reducing 5,174 holdings. Its most notable exit was Xilinx Inc, an estimated $186M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, UBS Group opened a new position in Shell worth $66.6M.
- UBS Group's largest Q1 2022 buy was Shell: 1,213,213 shares worth $66.6M.
- UBS Group added most to Tesla in Q1 2022, an estimated $388M increase.
- UBS Group's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $911M.
- UBS Group fully exited Xilinx Inc in Q1 2022, selling an estimated $186M.
- UBS Group's ten largest holdings make up 13% of its $300B portfolio in Q1 2022.
- UBS Group opened 1,181 new positions and closed 1,161 in Q1 2022.
- UBS Group's portfolio value fell 14% quarter-over-quarter to $300B.
Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.